Trial · NCT00911508
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Composite of Total Mortality, Disabling Stroke, Serious Bleeding, or Cardiac Arrest in Patients Warranting Therapy for AF. | From date of enrollment until time-to-first event over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With All-cause Mortality | From date of enrollment until date of death over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Mortality or Cardiovascular (CV) Hospitalization | From date of enrollment until time-to-first event of death or CV hospitalization over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Mortality, Disabling Stroke, or CV Hospitalization (for Heart Failure or Acute Ischemic Events) | From date of enrollment until time-to-first event of death, stroke, or CV hospitalization (for heart failure or acute ischemic event) over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Cardiovascular Death | From date of enrollment until date of a cardiovascular death over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Cardiovascular Death or Disabling Stroke | From date of enrollment until time-to-first event of a cardiovascular death or disabling stroke over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With an Arrhythmic Death or Cardiac Arrest | From date of enrollment until time-to-first event for an arrhythmic death or cardiac arrest over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Heart Failure Death | From date of enrollment until date of heart failure death over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants Free From Recurrent Atrial Fibrillation (AF) Following the 90 Day Blanking Period | From date of therapy initiation until date of first AF recurrence following a 90 day wait (blanking) period over a median follow-up of 48.5 months. | Subjects were analyzed in the post-blanking period if randomized treatment occurred and the subject did not die, withdraw, or get lost to follow-up before the end of the 90 day blanking period. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Cardiovascular Hospitalization | From date of enrollment until date of cardiovascular hospitalization over a median follow-up of 48.5 months. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Changes in Quality of Life Measures - AFEQT | Baseline ,12 month, 5 years | Only patients with questionnaire data were analyzed. | units on a scale | MEAN |
| SECONDARY | Changes in Quality of Life Measures - MAFSI Frequency Score | Baseline, 12 Month, 5 Year | Only patients with questionnaire data were analyzed. | units on a scale | MEAN |
| SECONDARY | Changes in Quality of Life Measures - MAFSI Severity Score | Baseline, 12 Month, 5 Year | Only patients with questionnaire data were analyzed. | units on a scale | MEAN |
| SECONDARY | Number of Participants With Adverse Events/Complications | From treatment start date to date of event over a median follow-up of 48.5 months. | Ablation-related events were counted among all patients that were randomized to and received an ablation.~Drug-related events were counted among all patients that were randomized to and received drug therapy. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00911508/outcomes